HomeQuestion
Would you consider the use of intrathecal chemotherapy in patients with diffuse spinal metastasis due to squamous cell lung cancer?
1 Answers
Mednet Member
Medical Oncology · Wexner Medical Center at The Ohio State University
My bias is that the response rate for IT chemotherapy for a non-oncogene driven cancer is low enough, that I typically do not consider this. Palliative radiation is reasonable, and in addition, while the question refers specifically to squamous cell lung cancer, this might be the situation in which ...